Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 16.001% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) N#Cc1c(N)c2ccccn2c1C(=O)c1ccc(Br)cc1
(b) O=S(=O)(c1ccc(SCCOc2cccc(Br)c2)nc1)N1CCCC1
(c) Cc1cc(C)c(NC(=O)CSc2nc3ncc(Br)cc3[nH]2)c(C)c1
Answer: a. N#Cc1c(N)c2ccccn2c1C(=O)c1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#Cc1c(N)c2ccccn2c1C(=O)c1ccc(Br)cc1
N#Cc1c(N)c2ccccn2c1C(=O)c1ccc(Br)cc1
1-amino-3-(4-bromobenzoyl)indolizine-2-carbonitrile